Literature DB >> 11659207

Attitudes of hospitalized patients toward life support: a survey of 200 medical inpatients.

David Frankl, Robert K Oye, Paul E Bellamy.   

Abstract

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; UCLA Medical Center (Los Angeles)

Mesh:

Year:  1989        PMID: 11659207

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  Advance directives: are they an advance? Advance Directives Seminar Group, Centre for Bioethics, University of Toronto.

Authors: 
Journal:  CMAJ       Date:  1992-01-15       Impact factor: 8.262

2.  Family physicians' attitudes toward advance directives.

Authors:  D L Hughes; P A Singer
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

Review 3.  Advance directives in family practice.

Authors:  N Kohut; P A Singer
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

4.  Bioethics for clinicians: 6. Advance care planning.

Authors:  P A Singer; G Robertson; D J Roy
Journal:  CMAJ       Date:  1996-12-15       Impact factor: 8.262

5.  Survey of Japanese physicians' attitudes towards the care of adult patients in persistent vegetative state.

Authors:  A Asai; M Maekawa; I Akiguchi; T Fukui; Y Miura; N Tanabe; S Fukuhara
Journal:  J Med Ethics       Date:  1999-08       Impact factor: 2.903

Review 6.  Increasing use of DNR orders in the elderly worldwide: whose choice is it?

Authors:  E P Cherniack
Journal:  J Med Ethics       Date:  2002-10       Impact factor: 2.903

7.  Resuscitating the elderly: what do the patients want?

Authors:  P Bruce-Jones; H Roberts; L Bowker; V Cooney
Journal:  J Med Ethics       Date:  1996-06       Impact factor: 2.903

8.  Minority race and male sex as risk factors for non-beneficial gastrostomy tube placements after stroke.

Authors:  Roland Faigle; Joseph A Carrese; Lisa A Cooper; Victor C Urrutia; Rebecca F Gottesman
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.